Akeso, Inc.

Informe acción SEHK:9926

Capitalización de mercado: HK$32.1b

Akeso Dirección

Dirección controles de criterios 3/4

El CEO de Akeso's es Michelle Xia , nombrado en Mar 2012, tiene una permanencia de 12.08 años. compensación anual total es CN¥5.27M, compuesta por 76.7% salario y 23.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 9.1% de las acciones de la empresa, por valor de HK$3.49B. La antigüedad media del equipo directivo y de la junta directiva es de 3.7 años y 4.4 años, respectivamente.

Información clave

Michelle Xia

Chief Executive Officer (CEO)

CN¥6.5m

Compensación total

Porcentaje del salario del CEO67.0%
Permanencia del CEO12.2yrs
Participación del CEO9.1%
Permanencia media de la dirección3.8yrs
Promedio de permanencia en la Junta Directiva4.5yrs

Actualizaciones recientes de la dirección

Recent updates

Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

Apr 24
Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

We Think Akeso's (HKG:9926) Robust Earnings Are Conservative

Mar 25
We Think Akeso's (HKG:9926) Robust Earnings Are Conservative

Results: Akeso, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Mar 20
Results: Akeso, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

Dec 28
Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 34% Undervalued

Nov 16
An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 34% Undervalued

Is Akeso (HKG:9926) Using Too Much Debt?

Oct 02
Is Akeso (HKG:9926) Using Too Much Debt?

The Akeso, Inc. (HKG:9926) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

Aug 31
The Akeso, Inc. (HKG:9926) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

Is Akeso, Inc. (HKG:9926) Trading At A 40% Discount?

Jun 26
Is Akeso, Inc. (HKG:9926) Trading At A 40% Discount?

There's Reason For Concern Over Akeso, Inc.'s (HKG:9926) Price

May 22
There's Reason For Concern Over Akeso, Inc.'s (HKG:9926) Price

Health Check: How Prudently Does Akeso (HKG:9926) Use Debt?

Apr 11
Health Check: How Prudently Does Akeso (HKG:9926) Use Debt?

Growth Investors: Industry Analysts Just Upgraded Their Akeso, Inc. (HKG:9926) Revenue Forecasts By 18%

Mar 21
Growth Investors: Industry Analysts Just Upgraded Their Akeso, Inc. (HKG:9926) Revenue Forecasts By 18%

An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 49% Undervalued

Mar 02
An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 49% Undervalued

Akeso, Inc.'s (HKG:9926) Intrinsic Value Is Potentially 95% Above Its Share Price

Nov 01
Akeso, Inc.'s (HKG:9926) Intrinsic Value Is Potentially 95% Above Its Share Price

Time To Worry? Analysts Are Downgrading Their Akeso, Inc. (HKG:9926) Outlook

Aug 28
Time To Worry? Analysts Are Downgrading Their Akeso, Inc. (HKG:9926) Outlook

Is Akeso (HKG:9926) Using Too Much Debt?

Apr 10
Is Akeso (HKG:9926) Using Too Much Debt?

Akeso (HKG:9926) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Dec 28
Akeso (HKG:9926) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Michelle Xia en comparación con los beneficios de Akeso?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023CN¥7mCN¥4m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥409m

Dec 31 2022CN¥5mCN¥4m

-CN¥1b

Sep 30 2022n/an/a

-CN¥1b

Jun 30 2022n/an/a

-CN¥1b

Mar 31 2022n/an/a

-CN¥1b

Dec 31 2021CN¥7mCN¥4m

-CN¥1b

Sep 30 2021n/an/a

-CN¥1b

Jun 30 2021n/an/a

-CN¥929m

Mar 31 2021n/an/a

-CN¥983m

Dec 31 2020CN¥7mCN¥3m

-CN¥1b

Sep 30 2020n/an/a

-CN¥870m

Jun 30 2020n/an/a

-CN¥703m

Mar 31 2020n/an/a

-CN¥492m

Dec 31 2019CN¥2mCN¥1m

-CN¥282m

Compensación vs. Mercado: La compensación total de Michelle($USD900.64K) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD486.11K).

Compensación vs. Ingresos: La compensación de Michelle ha sido consistente con los resultados de la empresa en el último año.


CEO

Michelle Xia (56 yo)

12.2yrs

Permanencia

CN¥6,524,000

Compensación

Dr. Yu Xia, Ph D., also known as Michelle, is CEO & President of Akeso Biopharma, Inc. Dr. Xia is Founder of Akeso, Inc. Dr. Xia is CEO, President & Chairwoman of Akeso, Inc. from March 19, 2012. She has b...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Yu Xia
Founder12.2yrsCN¥6.52m9.1%
CN¥ 2.9b
Baiyong Li
Co-Founder12.2yrsCN¥5.02m6.2%
CN¥ 2.0b
Zhongmin Wang
Co-Founderno dataCN¥3.60m5.22%
CN¥ 1.7b
Yu Xia
Senior VP & Executive Director4.5yrsCN¥33.65msin datos
Peng Zhang
Co-Founder & Senior VPno datasin datossin datos
Xinfeng Zhang
Senior Vice President3.8yrssin datossin datos
Wenjun Shi
Senior Vice President3.8yrssin datossin datos
Mingxiu Hu
Senior Vice President2.3yrssin datossin datos
Charlie Zhang
Senior Vice President1.3yrssin datossin datos
Jing Min
Senior Vice President1.3yrssin datossin datos
Wai Yan Leung
Company Secretary1.8yrssin datossin datos

3.8yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 9926 se considera experimentado (3.7 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Yu Xia
Founder12.2yrsCN¥6.52m9.1%
CN¥ 2.9b
Baiyong Li
Co-Founder4.5yrsCN¥5.02m6.2%
CN¥ 2.0b
Zhongmin Wang
Co-Founder4.5yrsCN¥3.60m5.22%
CN¥ 1.7b
Yu Xia
Senior VP & Executive Director4.5yrsCN¥33.65msin datos
Bo Tan
Independent Non-Executive Directorno dataCN¥317.00ksin datos
Ronggang Xie
Non-Executive Director3.8yrssin datossin datos
Yi Zhou
Non-Executive Director4.5yrssin datossin datos
Yan Xu
Independent Non-Executive Directorno dataCN¥319.00ksin datos
Junwen Zeng
Independent Non-Executive Directorno dataCN¥317.00ksin datos

4.5yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de 9926 se considera experimentada (4.4 años de antigüedad promedio).